Tharimmune, Inc. — Director's Dealing 2025

Aug 20, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2025-04-28

Reporting Person: Stetz Gary S. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	101351	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.33	2035-08-04	Common Stock (50000)		Direct
Series A Warrants	$1.29	2030-12-13	Common Stock (101351)		Direct
Series B Warrants	$3.00	2030-12-13	Common Stock (50675)		Direct

Footnotes

F1: 25,000 of the options vest on date of grant and 25,000 vest on August 4, 2026.